An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives.

Documenti analoghi

• New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic with 2',3'-dideoxynucleoside analogs.
  di: Pauwels, R, et al.
  Pubblicazione: (1994)
• Chemical crosslinking of the subunits of HIV-1 reverse transcriptase.
  di: Debyser, Z., et al.
  Pubblicazione: (1996)
• TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1
  di: Andries, Koen, et al.
  Pubblicazione: (2004)
• Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.
  di: Pauwels, R, et al.
  Pubblicazione: (1993)
• 1-Benzyl-3-[(dimethyl­amino)methyl­ene]-4-phenyl-1H-1,5-benzodiazepine-2(3H)-thione
  di: Ballo, Daouda, et al.
  Pubblicazione: (2010)